OMERS ADMINISTRATION Corp Purchases 330 Shares of Teleflex Incorporated (NYSE:TFX)

OMERS ADMINISTRATION Corp boosted its position in shares of Teleflex Incorporated (NYSE:TFX) by 20.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,957 shares of the medical technology company’s stock after purchasing an additional 330 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Teleflex were worth $348,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. CANADA LIFE ASSURANCE Co grew its stake in Teleflex by 0.4% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company’s stock worth $3,614,000 after acquiring an additional 74 shares in the last quarter. Hengehold Capital Management LLC grew its stake in Teleflex by 7.3% in the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after acquiring an additional 88 shares in the last quarter. Exchange Traded Concepts LLC grew its stake in Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock worth $61,000 after acquiring an additional 94 shares in the last quarter. Isthmus Partners LLC grew its stake in Teleflex by 7.3% in the 4th quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock worth $273,000 after acquiring an additional 105 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in Teleflex by 2.4% in the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company’s stock worth $888,000 after acquiring an additional 118 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Trading Down 0.9%

NYSE TFX opened at $128.14 on Tuesday. The company has a fifty day simple moving average of $132.68 and a two-hundred day simple moving average of $161.79. The stock has a market cap of $5.66 billion, a P/E ratio of 25.48, a P/E/G ratio of 1.73 and a beta of 1.17. Teleflex Incorporated has a 12-month low of $120.06 and a 12-month high of $249.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.88 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $700.67 million during the quarter, compared to analysts’ expectations of $699.37 million. During the same quarter last year, the company posted $3.21 earnings per share. The firm’s revenue was down 5.0% compared to the same quarter last year. On average, analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, May 20th. This represents a $1.36 annualized dividend and a dividend yield of 1.06%. Teleflex’s dividend payout ratio (DPR) is presently 42.90%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Truist Financial dropped their price objective on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating on the stock in a research note on Monday, May 5th. Raymond James downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Royal Bank of Canada dropped their price objective on shares of Teleflex from $150.00 to $145.00 and set a “sector perform” rating on the stock in a research note on Friday, May 2nd. Finally, Mizuho set a $155.00 price objective on shares of Teleflex in a research note on Wednesday, April 16th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $164.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.